BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20153316)

  • 1. Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord.
    Bianchi BR; El Kouhen R; Chen J; Puttfarcken PS
    Eur J Pharmacol; 2010 May; 633(1-3):15-23. PubMed ID: 20153316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
    Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
    J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
    McDonald HA; Neelands TR; Kort M; Han P; Vos MH; Faltynek CR; Moreland RB; Puttfarcken PS
    Eur J Pharmacol; 2008 Oct; 596(1-3):62-9. PubMed ID: 18755179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
    Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid.
    El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of ELISA to measure TRPV1 protein in rat tissues.
    Han P; Korepanova AV; Vos MH; Pereda-Lopez A; Lake MR; Bianchi BR; Moreland RB; Faltynek CR; Chiu ML
    J Neurosci Methods; 2011 Sep; 200(2):144-52. PubMed ID: 21762727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG).
    Woo DH; Jung SJ; Zhu MH; Park CK; Kim YH; Oh SB; Lee CJ
    Mol Pain; 2008 Oct; 4():42. PubMed ID: 18826653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity.
    Ursu D; Knopp K; Beattie RE; Liu B; Sher E
    Eur J Pharmacol; 2010 Sep; 641(2-3):114-22. PubMed ID: 20576527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors.
    McHugh D; McMaster RS; Pertwee RG; Roy S; Mahadevan A; Razdan RK; Ross RA
    J Pharmacol Exp Ther; 2006 Feb; 316(2):955-65. PubMed ID: 16207832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level.
    Spicarova D; Palecek J
    J Neurophysiol; 2009 Jul; 102(1):234-43. PubMed ID: 19369364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.
    Szallasi A; Goso C; Blumberg PM; Manzini S
    J Pharmacol Exp Ther; 1993 Nov; 267(2):728-33. PubMed ID: 8246148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-inhibition between native and recombinant TRPV1 and P2X(3) receptors.
    Stanchev D; Blosa M; Milius D; Gerevich Z; Rubini P; Schmalzing G; Eschrich K; Schaefer M; Wirkner K; Illes P
    Pain; 2009 May; 143(1-2):26-36. PubMed ID: 19223122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPV1b overexpression negatively regulates TRPV1 responsiveness to capsaicin, heat and low pH in HEK293 cells.
    Vos MH; Neelands TR; McDonald HA; Choi W; Kroeger PE; Puttfarcken PS; Faltynek CR; Moreland RB; Han P
    J Neurochem; 2006 Nov; 99(4):1088-102. PubMed ID: 17018028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine.
    Sadofsky LR; Campi B; Trevisani M; Compton SJ; Morice AH
    Exp Lung Res; 2008 Dec; 34(10):681-93. PubMed ID: 19085565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of phenylpropanamides as novel transient receptor potential vanilloid 1 antagonists.
    Li FN; Kim NJ; Nam YH; Kim SH; Seo SY; Jeong YS; Kim SY; Park YH; Suh YG
    Arch Pharm Res; 2009 Sep; 32(9):1201-10. PubMed ID: 19784574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenon reduces activation of transient receptor potential vanilloid type 1 (TRPV1) in rat dorsal root ganglion cells and in human TRPV1-expressing HEK293 cells.
    White JP; Calcott G; Jenes A; Hossein M; Paule CC; Santha P; Davis JB; Ma D; Rice AS; Nagy I
    Life Sci; 2011 Jan; 88(3-4):141-9. PubMed ID: 21056583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line.
    Szoke E; Börzsei R; Tóth DM; Lengl O; Helyes Z; Sándor Z; Szolcsányi J
    Eur J Pharmacol; 2010 Feb; 628(1-3):67-74. PubMed ID: 19958765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
    De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TRPV1 receptor is associated with preferential stress in large dorsal root ganglion neurons in early diabetic sensory neuropathy.
    Hong S; Agresta L; Guo C; Wiley JW
    J Neurochem; 2008 May; 105(4):1212-22. PubMed ID: 18182051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.